Should iShares Russell 2000 Growth ETF (IWO) Be on Your Investing Radar? [Yahoo! Finance]
Vaxcyte, Inc. (PCVX)
Company Research
Source: Yahoo! Finance
The iShares Russell 2000 Growth ETF (IWO) was launched on 07/24/2000, and is a passively managed exchange traded fund designed to offer broad exposure to the Small Cap Growth segment of the US equity market. The fund is sponsored by Blackrock. It has amassed assets over $11.93 billion, making it one of the largest ETFs attempting to match the Small Cap Growth segment of the US equity market. Why Small Cap Growth Small cap companies have market capitalization below $2 billion. They usually have higher potential than large and mid cap companies with stocks but higher risk. Qualities of growth stocks include faster growth rates compared to the broader market, as well as higher valuations and higher than average sales and earnings growth rates. Something to keep in mind is the higher level of volatility that is affiliated with growth stocks. Compared to value stocks, growth stocks are a safer bet in a strong bull market, but don't perform as strongly in almost all other financial
Show less
Read more
Impact Snapshot
Event Time:
PCVX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PCVX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PCVX alerts
High impacting Vaxcyte, Inc. news events
Weekly update
A roundup of the hottest topics
PCVX
News
- Vaxcyte to Present at the 2024 Cantor Global Healthcare ConferenceGlobeNewswire
- Vaxcyte, Inc. (NASDAQ: PCVX) had its price target raised by analysts at Mizuho from $113.00 to $163.00. They now have an "outperform" rating on the stock.MarketBeat
- Vaxcyte's Broad-Spectrum Pneumococcal Vaccines Poised For Market Dominance By 2027 [Seeking Alpha]Seeking Alpha
- Vaxcyte: Stunning PCV Data Readout Suggests Vaccine Maker Is A Strong Buy [Seeking Alpha]Seeking Alpha
- Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional SharesGlobeNewswire
PCVX
Earnings
- 5/8/24 - Beat
PCVX
Sec Filings
- 9/19/24 - Form 4
- 9/18/24 - Form 4
- 9/18/24 - Form 4
- PCVX's page on the SEC website